| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 34,533 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 37,708 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 45,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 38,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 50,974 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 14,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | May 14 | D | 82,500 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 7,363 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 6,001 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 11,874 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 55,986 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 32,072 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 55,986 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | A | 55,986 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 27,993 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | A | 27,993 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 28,508 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | A | 28,508 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | D | 41,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | A | 41,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | U | 50,136 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | U | 10,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | May 14 | U | 144,517 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Jan 28 | A | 55,986 | $0.00 | — |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Jan 22 | S | 7,832 | $21.77 | $170K |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Jan 20 | S | 2,475 | $19.79 | $49K |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Jan 13 | S | 5,780 | $22.19 | $128K |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGCDERIV | Jan 7 | MPLAN | 888 | $0.00 | —? |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Jan 7 | MPLAN | 888 | $14.95 | $13K |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Dec 16 | SPLAN | 5,000 | $24.49 | $122K |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Nov 17 | SPLAN | 5,000 | $20.06 | $100K |
| Apellis Pharmaceuticals, Inc. | APLS | David O. WatsonGC | Oct 16 | SPLAN | 5,000 | $25.22 | $126K |